UCBJY:OTCMKTS
UCB Unsponsored Belgium ADR
US$ १६३.७५
arrow_upward
+०.८३%(+१.३५) 1D
नोभेम्बर १३, १६:००:०० GMT-५ · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for UCBJY...
Open
US$ १६३.४२
High
US$ १६४.३३
Low
US$ १६२.५१
Mkt. cap
५७.५० अरब
Avg. vol.
४३.९६ हजार
Volume
०.००
52-wk high
US$ १६८.७६
52-wk low
US$ ११०.५५
Beta
०.५१
Shares outstanding
३८.९० करोड
No. of employees
९ हजार
Open
US$ १६३.४२
High
US$ १६४.३३
Low
US$ १६२.५१
Mkt. cap
५७.५० अरब
Avg. vol.
४३.९६ हजार
Volume
०.००
52-wk high
US$ १६८.७६
52-wk low
US$ ११०.५५
Beta
०.५१
Shares outstanding
३८.९० करोड
No. of employees
९ हजार
News stories
From web sources and news partners
Reuters
·
१ घण्टा पहिले
S&P 500, Nasdaq futures slide as Nvidia earnings, Anthropic debut loom
Yahoo Finance
·
५१ मिनेट पहिले
Stock market today: Dow, S&P 500, Nasdaq futures little changed ahead of pivotal week for AI traders
Reuters
·
३ दिन पहिले
S&P 500, Nasdaq end lower as Nvidia uncertainty weighs on tech shares
Business Insider
·
१ घण्टा पहिले
A veteran strategist sees a split in the stock market leading to a 15% drop in the S&P 500
Profile
UCB is a multinational biopharmaceutical company headquartered in Brussels, Belgium. UCB is an international company with revenue of €4.178 billion in 2016 which focuses primarily on research and development, specifically involving medications centered on epilepsy, Parkinson's disease, and Crohn's disease. The company's efforts are focused on treatments for severe diseases treated by specialists, particularly in the fields of central nervous system disorders, inflammatory disorders, and oncology.
Every three years, the company presents the UCB Award under the patronage of the Queen Elisabeth Medical Foundation to promote neuroscience research. The winner of this award is selected by an independent scientific committee. Wikipedia
About UCB Unsponsored Belgium ADR
CEOJean-Christophe Tellier
Employees९ हजार
Founded१९२८ जनवरी १८
Headquarters-
SectorHealth Care
Industry-
Websiteucb.com